Cargando…
Lactiplantibacillus plantarum DSM20174 Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, reaching epidemic proportions worldwide. Targeting the gut–adipose tissue–liver axis by modulating the gut microbiota can be a promising therapeutic approach in NAFLD. Lactiplantibacillus plantarum, a potent...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787191/ https://www.ncbi.nlm.nih.gov/pubmed/36558371 http://dx.doi.org/10.3390/nu14245212 |
_version_ | 1784858457419022336 |
---|---|
author | Riezu-Boj, José I. Barajas, Miguel Pérez-Sánchez, Tania Pajares, María J. Araña, Miriam Milagro, Fermín I. Urtasun, Raquel |
author_facet | Riezu-Boj, José I. Barajas, Miguel Pérez-Sánchez, Tania Pajares, María J. Araña, Miriam Milagro, Fermín I. Urtasun, Raquel |
author_sort | Riezu-Boj, José I. |
collection | PubMed |
description | Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, reaching epidemic proportions worldwide. Targeting the gut–adipose tissue–liver axis by modulating the gut microbiota can be a promising therapeutic approach in NAFLD. Lactiplantibacillus plantarum, a potent lactic-acid-producing bacterium, has been shown to attenuate NAFLD. However, to our knowledge, the possible effect of the Lactiplantibacillus plantarum strain DSM20174 (L.p. DSM20174) on the gut–adipose tissue axis, diminishing inflammatory mediators as fuel for NAFLD progression, is still unknown. Using a NAFLD mouse model fed a high-fat, high-fructose (HFHF) diet for 10 weeks, we show that L.p DSM20174 supplementation of HFHF mice prevented weight gain, improved glucose and lipid homeostasis, and reduced white adipose inflammation and NAFLD progression. Furthermore, 16S rRNA gene sequencing of the faecal microbiota suggested that treatment of HFHF-fed mice with L.p DSM20174 changed the diversity and altered specific bacterial taxa at the levels of family, genus, and species in the gut microbiota. In conclusion, the beneficial effects of L.p DSM20174 in preventing fatty liver progression may be related to modulations in the composition and potential function of gut microbiota associated with lower metabolic risk factors and a reduced M1-like/M2-like ratio of macrophages and proinflammatory cytokine expression in white adipose tissue and liver. |
format | Online Article Text |
id | pubmed-9787191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97871912022-12-24 Lactiplantibacillus plantarum DSM20174 Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation Riezu-Boj, José I. Barajas, Miguel Pérez-Sánchez, Tania Pajares, María J. Araña, Miriam Milagro, Fermín I. Urtasun, Raquel Nutrients Article Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, reaching epidemic proportions worldwide. Targeting the gut–adipose tissue–liver axis by modulating the gut microbiota can be a promising therapeutic approach in NAFLD. Lactiplantibacillus plantarum, a potent lactic-acid-producing bacterium, has been shown to attenuate NAFLD. However, to our knowledge, the possible effect of the Lactiplantibacillus plantarum strain DSM20174 (L.p. DSM20174) on the gut–adipose tissue axis, diminishing inflammatory mediators as fuel for NAFLD progression, is still unknown. Using a NAFLD mouse model fed a high-fat, high-fructose (HFHF) diet for 10 weeks, we show that L.p DSM20174 supplementation of HFHF mice prevented weight gain, improved glucose and lipid homeostasis, and reduced white adipose inflammation and NAFLD progression. Furthermore, 16S rRNA gene sequencing of the faecal microbiota suggested that treatment of HFHF-fed mice with L.p DSM20174 changed the diversity and altered specific bacterial taxa at the levels of family, genus, and species in the gut microbiota. In conclusion, the beneficial effects of L.p DSM20174 in preventing fatty liver progression may be related to modulations in the composition and potential function of gut microbiota associated with lower metabolic risk factors and a reduced M1-like/M2-like ratio of macrophages and proinflammatory cytokine expression in white adipose tissue and liver. MDPI 2022-12-07 /pmc/articles/PMC9787191/ /pubmed/36558371 http://dx.doi.org/10.3390/nu14245212 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Riezu-Boj, José I. Barajas, Miguel Pérez-Sánchez, Tania Pajares, María J. Araña, Miriam Milagro, Fermín I. Urtasun, Raquel Lactiplantibacillus plantarum DSM20174 Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation |
title | Lactiplantibacillus plantarum DSM20174 Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation |
title_full | Lactiplantibacillus plantarum DSM20174 Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation |
title_fullStr | Lactiplantibacillus plantarum DSM20174 Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation |
title_full_unstemmed | Lactiplantibacillus plantarum DSM20174 Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation |
title_short | Lactiplantibacillus plantarum DSM20174 Attenuates the Progression of Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota, Improving Metabolic Risk Factors, and Attenuating Adipose Inflammation |
title_sort | lactiplantibacillus plantarum dsm20174 attenuates the progression of non-alcoholic fatty liver disease by modulating gut microbiota, improving metabolic risk factors, and attenuating adipose inflammation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787191/ https://www.ncbi.nlm.nih.gov/pubmed/36558371 http://dx.doi.org/10.3390/nu14245212 |
work_keys_str_mv | AT riezubojjosei lactiplantibacillusplantarumdsm20174attenuatestheprogressionofnonalcoholicfattyliverdiseasebymodulatinggutmicrobiotaimprovingmetabolicriskfactorsandattenuatingadiposeinflammation AT barajasmiguel lactiplantibacillusplantarumdsm20174attenuatestheprogressionofnonalcoholicfattyliverdiseasebymodulatinggutmicrobiotaimprovingmetabolicriskfactorsandattenuatingadiposeinflammation AT perezsancheztania lactiplantibacillusplantarumdsm20174attenuatestheprogressionofnonalcoholicfattyliverdiseasebymodulatinggutmicrobiotaimprovingmetabolicriskfactorsandattenuatingadiposeinflammation AT pajaresmariaj lactiplantibacillusplantarumdsm20174attenuatestheprogressionofnonalcoholicfattyliverdiseasebymodulatinggutmicrobiotaimprovingmetabolicriskfactorsandattenuatingadiposeinflammation AT aranamiriam lactiplantibacillusplantarumdsm20174attenuatestheprogressionofnonalcoholicfattyliverdiseasebymodulatinggutmicrobiotaimprovingmetabolicriskfactorsandattenuatingadiposeinflammation AT milagrofermini lactiplantibacillusplantarumdsm20174attenuatestheprogressionofnonalcoholicfattyliverdiseasebymodulatinggutmicrobiotaimprovingmetabolicriskfactorsandattenuatingadiposeinflammation AT urtasunraquel lactiplantibacillusplantarumdsm20174attenuatestheprogressionofnonalcoholicfattyliverdiseasebymodulatinggutmicrobiotaimprovingmetabolicriskfactorsandattenuatingadiposeinflammation |